Currently, the drugs are very expensive and are not yet covered for weight loss by some insurance companies
Abstracts Cuglievan B , Jen WY, Short NJ, Bataller A, DiNardo CD, Loghavi S, Daver N, MD, Farhat A, Hajjar GE, McCall D, Gibson A, Garcia M, Nunez C, Roth M, Kadia TM, Bazinet A, Jabbour E, Montalban-Bravo G, Ravandi F, Garcia-Manero G, Andreeff M , Kantarjian HM, Issa GC
Nausea, when it occurs, tends to be most intense during weeks 13-14 and resolves significantly by week 15-16
KPV is a small tripeptide, which makes it generally more stable than larger peptides
N Engl J Med 387 , 205216 (2022)
Cagrilintides most well-known clinical synergy is with semaglutide, where it is being studied as part of a combination therapy to enhance weight loss outcomes